Inogen, Inc. (INGN)
INGN Stock Price Chart
Explore Inogen, Inc. interactive price chart. Choose custom timeframes to analyze INGN price movements and trends.
INGN Company Profile
Discover essential business fundamentals and corporate details for Inogen, Inc. (INGN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
14 Feb 2014
Employees
766.00
Website
https://www.inogen.comCEO
Kevin R. M. Smith
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
INGN Financial Timeline
Browse a chronological timeline of Inogen, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 23 Feb 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.24, while revenue estimate is $92.13M.
Earnings released on 7 Aug 2025
EPS came in at -$0.15 surpassing the estimated -$0.22 by +31.82%, while revenue for the quarter reached $92.28M , missing expectations by -1.06%.
Earnings released on 7 May 2025
EPS came in at -$0.25 surpassing the estimated -$0.52 by +51.92%, while revenue for the quarter reached $82.28M , missing expectations by -11.27%.
Earnings released on 25 Feb 2025
EPS came in at -$0.41 surpassing the estimated -$0.56 by +26.79%, while revenue for the quarter reached $80.08M , beating expectations by +8.36%.
Earnings released on 7 Nov 2024
EPS came in at -$0.25 surpassing the estimated -$0.51 by +50.98%, while revenue for the quarter reached $88.83M , beating expectations by +20.21%.
Earnings released on 6 Aug 2024
EPS came in at -$0.24 surpassing the estimated -$0.54 by +55.56%, while revenue for the quarter reached $88.77M , beating expectations by +7.59%.
Earnings released on 7 May 2024
EPS came in at -$0.62 surpassing the estimated -$0.76 by +18.42%, while revenue for the quarter reached $78.03M , beating expectations by +5.93%.
Earnings released on 27 Feb 2024
EPS came in at -$1.14 falling short of the estimated -$0.65 by -75.38%, while revenue for the quarter reached $75.90M , missing expectations by -1.42%.
Earnings released on 7 Nov 2023
EPS came in at -$1.97 falling short of the estimated -$0.57 by -245.61%, while revenue for the quarter reached $83.97M , beating expectations by +1.83%.
Earnings released on 7 Aug 2023
EPS came in at -$0.42 surpassing the estimated -$0.64 by +34.38%, while revenue for the quarter reached $83.64M , missing expectations by -9.29%.
Earnings released on 4 May 2023
EPS came in at -$0.63 surpassing the estimated -$0.77 by +18.18%, while revenue for the quarter reached $72.16M , missing expectations by -3.37%.
Earnings released on 23 Feb 2023
EPS came in at -$0.57 surpassing the estimated -$0.60 by +5.00%, while revenue for the quarter reached $88.09M , missing expectations by -1.57%.
Earnings released on 2 Nov 2022
EPS came in at -$0.18 surpassing the estimated -$0.41 by +56.10%, while revenue for the quarter reached $105.39M , beating expectations by +7.85%.
Earnings released on 4 Aug 2022
EPS came in at -$0.02 surpassing the estimated -$0.40 by +95.00%, while revenue for the quarter reached $103.38M , beating expectations by +2.72%.
Earnings released on 5 May 2022
EPS came in at -$0.38 surpassing the estimated -$0.48 by +20.83%, while revenue for the quarter reached $80.39M , beating expectations by +5.00%.
Earnings released on 24 Feb 2022
EPS came in at -$1.01 falling short of the estimated -$0.74 by -36.49%, while revenue for the quarter reached $76.40M , beating expectations by +0.56%.
Earnings released on 4 Nov 2021
EPS came in at $0.53 surpassing the estimated -$0.26 by +303.85%, while revenue for the quarter reached $93.11M , beating expectations by +5.32%.
Earnings released on 4 Aug 2021
EPS came in at $0.22 surpassing the estimated -$0.11 by +300.00%, while revenue for the quarter reached $101.56M , meeting expectations.
Earnings released on 4 May 2021
EPS came in at -$0.03 surpassing the estimated -$0.28 by +89.29%, while revenue for the quarter reached $86.93M , missing expectations by -41.18%.
Earnings released on 24 Feb 2021
EPS came in at -$0.23 surpassing the estimated -$0.28 by +17.86%, while revenue for the quarter reached $73.98M , missing expectations by -10.34%.
Earnings released on 4 Nov 2020
EPS came in at -$0.08 falling short of the estimated -$0.02 by -290.24%, while revenue for the quarter reached $74.33M , beating expectations by +300.00%.
INGN Stock Performance
Access detailed INGN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.